Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 7 studies | 38% ± 18% | |
ciliated cell | 6 studies | 22% ± 5% | |
epithelial cell | 6 studies | 35% ± 15% | |
adipocyte | 6 studies | 20% ± 2% | |
basal cell | 6 studies | 31% ± 16% | |
type II pneumocyte | 6 studies | 22% ± 7% | |
squamous epithelial cell | 4 studies | 46% ± 15% | |
cardiac muscle cell | 4 studies | 25% ± 3% | |
respiratory goblet cell | 4 studies | 29% ± 10% | |
type I pneumocyte | 4 studies | 18% ± 3% | |
club cell | 4 studies | 21% ± 4% | |
secretory cell | 3 studies | 23% ± 4% | |
hepatocyte | 3 studies | 53% ± 26% | |
glutamatergic neuron | 3 studies | 42% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 31% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 6289.34 | 89 / 89 | 98% | 23.92 | 884 / 901 |
thymus | 100% | 2889.53 | 651 / 653 | 98% | 14.09 | 594 / 605 |
pancreas | 100% | 2876.38 | 328 / 328 | 98% | 13.94 | 174 / 178 |
liver | 100% | 5572.17 | 226 / 226 | 97% | 12.70 | 395 / 406 |
prostate | 91% | 2258.23 | 222 / 245 | 100% | 14.52 | 500 / 502 |
lung | 87% | 1488.18 | 500 / 578 | 98% | 14.33 | 1132 / 1155 |
breast | 86% | 1654.41 | 393 / 459 | 97% | 15.20 | 1086 / 1118 |
stomach | 75% | 1827.87 | 271 / 359 | 97% | 17.60 | 277 / 286 |
intestine | 49% | 1344.25 | 478 / 966 | 98% | 19.87 | 518 / 527 |
esophagus | 45% | 1601.74 | 648 / 1445 | 99% | 17.93 | 182 / 183 |
bladder | 38% | 815.05 | 8 / 21 | 97% | 14.09 | 490 / 504 |
skin | 75% | 5568.73 | 1348 / 1809 | 56% | 4.53 | 266 / 472 |
uterus | 15% | 239.85 | 25 / 170 | 94% | 14.09 | 432 / 459 |
muscle | 100% | 12457.93 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.91 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.30 | 1 / 1 |
ovary | 8% | 70.56 | 14 / 180 | 92% | 8.57 | 394 / 430 |
blood vessel | 97% | 2037.73 | 1298 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 33% | 303.10 | 85 / 258 | 63% | 5.33 | 146 / 230 |
heart | 76% | 2659.76 | 653 / 861 | 0% | 0 | 0 / 0 |
adipose | 74% | 976.52 | 890 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 68% | 4.85 | 54 / 80 |
brain | 31% | 469.33 | 820 / 2642 | 15% | 0.98 | 104 / 705 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.18 | 1 / 29 |
peripheral blood | 1% | 11.40 | 7 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 10.25 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000649 | Biological process | regulation of sodium ion transmembrane transporter activity |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0000165 | Biological process | MAPK cascade |
GO_0042059 | Biological process | negative regulation of epidermal growth factor receptor signaling pathway |
GO_0051045 | Biological process | negative regulation of membrane protein ectodomain proteolysis |
GO_0097421 | Biological process | liver regeneration |
GO_0045930 | Biological process | negative regulation of mitotic cell cycle |
GO_0098902 | Biological process | regulation of membrane depolarization during action potential |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0051117 | Molecular function | ATPase binding |
GO_0017080 | Molecular function | sodium channel regulator activity |
GO_0008092 | Molecular function | cytoskeletal protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0001784 | Molecular function | phosphotyrosine residue binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | PTPN3 |
Protein name | Tyrosine-protein phosphatase non-receptor type 3 (EC 3.1.3.48) (Protein-tyrosine phosphatase H1) (PTP-H1) Tyrosine-protein phosphatase non-receptor type (EC 3.1.3.48) |
Synonyms | PTPH1 |
Description | FUNCTION: May act at junctions between the membrane and the cytoskeleton. Possesses tyrosine phosphatase activity. FUNCTION: May act at junctions between the membrane and the cytoskeleton. . FUNCTION: May act at junctions between the membrane and the cytoskeleton. . |
Accessions | B7Z9V1 ENST00000446349.5 [P26045-3] P26045 ENST00000262539.7 J3KN34 ENST00000374541.4 [P26045-1] ENST00000412145.5 [P26045-2] |